Yahoo Finance

DECN Adds International Distribution for its Genultimate, Genchoice, Genprecis and Gensure Products

LOS ANGELES, CA / ACCESSWIRE / September 4, 2019 / Decision Diagnostics Corp. (OTC PINK:DECN) is a 17-year old, diabetes-focused bio-technology development firm, manufacturer, quality plan ...
Yahoo Finance

DECN Board Of Directors In Final Review Of Preliminary Financing Agreement For $4.75 Million Investment

LOS ANGELES, CA / ACCESSWIRE / September 13, 2018 / Decision Diagnostics Corp. (OTC PINK: DECN) is a 16 year old, diabetes-focused bio-technology R&D firm, manufacturer, quality plan administrator, ...
Nasdaq

DECN to Immediately Take Control of Two Market Ready, FDA Cleared, Glucose Monitoring Systems to Augment Its Primary Marketplace Positions

Company Adding A Low End System For Sale On Amazon, Walmart & Other Sites, While Second System With A Multi-Patient Monitor Is Perfect For Nursing Homes & Clinics DECN announces today that we have ...
Nasdaq

DECN Enters Exciting New Phase After High Court Hearing, Long Running Legal Battles With Johnson & Johnson Are Nearing A Positive Ending

Company's Confidence Grows On The Back Of Recent Rulings And Court Room Events Strengthening An Already Strong Case With Huge Settlement Potential Much of the misinformation and several of the rulings ...
Newsweek

CEO Charged With Fraud in 15-Second COVID Test Scheme

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Keith Berman, the CEO of Decision Diagnostics Corporation (DECN), was ...
Benzinga.com

Decision Diagnostics (DECN) Stock Price, Quote, News & History

Get real-time Decision Diagnostics (DECN) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to inform your investment decisions.
Seeking Alpha

DECN Decision Diagnostics Corp.

Decision Diagnostics Corp. develops smart phone based electronic medical record (EMR) technologies. The company offers prescription and non-prescription diagnostics; home testing products for the ...
Business Insider

DECN Issues Support for Recently Announced FDA COVID-19 At-Home Testing Template as the Company's Submission for Its Genviro! Swift COVID-19 At-Home Test Kit Anticipated Many ...

FDA Commissioner Dr. Stephen Hahn says, "These types of tests will be a game changer" LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics ...
Business Insider

DECN Enters into a New 6 Month $300,000 Promissory Note with Major Current Investor to Help Fund the Recent International Launch if its GenViro! Swift Kits

LOS ANGELES, CA / ACCESSWIRE / October 5, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., the manufacturers and design specifiers for the :10.5 ...
Business Wire

DECN EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Decision Diagnostics Corp. – DECN

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Decision Diagnostics Corp. (OTC: ...
Business Wire

DECN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Decision Diagnostics Corp. Investors of Class Action and Encourages Shareholders to Contact the Firm

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Decision Diagnostics Corp. ("Decision" or "the Company") (OTC: DECN) ...
Seeking Alpha

DECN Decision Diagnostics Corp.

Decision Diagnostics Corp. (DECN) momentum performance and underlying metrics. Price return vs. S&P 500, Quant Ratings. Charts: from 1 month to 10 years and stock comparison.